dsip-texas S-CONNECT DSIP | Sleep & Neuroregulatory

The concentration printed on a label from an unregulated source is not verified

When incorporated into a Glow Peptide Injection protocol, they help repair micro-damage to the skins structure

Reported Limitations and Considerations in GHK-Cu Research Gaps in the Current Evidence Base Despite a substantial pre-clinical record, GHK-Cu lacks large-scale human clinical trial data for most reported applications

At 20 years, the average concentration of GHK-Cu of 200 ng/mL declines to 80 ng/mL by 60 years

Avoid other actives, retinoids, acids, vitamin C, during the GHK-CU introduction period

DSIP in the treatment of withdrawal syndromes from alcohol and opiates